Anika Therapeutics Inc. (ANIK)
Company Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally.
The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform.
Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products.
The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products.
Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Country | United States |
IPO Date | May 3, 1993 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 288 |
CEO | Dr. Cheryl Renee Blanchard Ph.D. |
Contact Details
Address: 32 Wiggins Avenue Bedford, Massachusetts United States | |
Website | https://www.anikatherapeutics.com |
Stock Details
Ticker Symbol | ANIK |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000898437 |
CUSIP Number | 035255108 |
ISIN Number | US0352551081 |
Employer ID | 04-3145961 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dr. Cheryl Renee Blanchard Ph.D. | President, Chief Executive Officer & Director |
Anne Nunes | Senior Vice President & Chief Operating Officer |
Stephen D. Griffin | Executive Vice President, Chief Financial Officer & Treasurer |
Ben Joseph | Vice President of Commercial & Corporate Development |
David Colleran J.D. | Executive Vice President, General Counsel & Corporate Secretary |
Ian W. McLeod | Vice President & Chief Accounting Officer |
James Chase | Senior Vice President of International Sales & Marketing |
Lisa Funiciello | Vice President of Human Resources |
Mark Namaroff | Vice President of Investor Relations, ESG & Corporate Communications |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 18, 2025 | 4 | Filing |
Mar 18, 2025 | 4 | Filing |
Mar 18, 2025 | 4 | Filing |
Mar 18, 2025 | 4 | Filing |
Mar 17, 2025 | 10-K | Annual Report |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 12, 2025 | 8-K | Current Report |
Mar 11, 2025 | 4 | Filing |